Crossmark

Risk factors for losing hepatitis B virus surface antibody in patients with HBV surface antigen negative/surface antibody positive serostatus receiving biologic disease-modifying anti-rheumatic drugs: a nested case-control study

Crossref DOI link: https://doi.org/10.1186/s42358-021-00173-9

Published Online: 2021-04-08

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hung, Ming-Hui

Tien, Ya-Chih

Chiu, Ying-Ming http://orcid.org/0000-0003-4548-5331
License Information

Text and Data Mining valid from 2021-04-08

Version of Record valid from 2021-04-08
More Information

Article History

Received: 29 September 2020

Accepted: 26 February 2021

First Online: 8 April 2021

Declarations

:

: This study was performed in accordance with the ethical standards established by the 1964 Declaration of Helsinki and its later amendments. All participants provided written informed consent before any study-related procedure ensued.Changhua Christian Hospital Institutional Review Board approved the study protocol.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below